Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | 360.00K | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | 360.00K | -- | -- |
Cost of Revenue | -- | -- | 296.00K | -- | -- |
Gross Profit | -- | -- | 64.00K | -- | -- |
SG&A Expenses | 1.32M | 1.48M | 1.48M | 1.49M | 1.48M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.19M | 4.00M | 4.29M | 4.01M | 4.00M |
Operating Income | -3.19M | -4.00M | -3.93M | -4.01M | -4.00M |
Income Before Tax | -3.20M | -4.00M | -3.93M | -4.01M | -4.00M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -3.20M | -4.00M | -3.93M | -4.01M | -4.00M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -3.20M | -4.00M | -3.93M | -4.01M | -4.00M |
EBIT | -3.19M | -4.00M | -3.93M | -4.01M | -4.00M |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.05 | -0.07 | -0.07 | -0.07 | -0.07 |
Normalized Basic EPS | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 |
EPS Diluted | -0.05 | -0.07 | -0.07 | -0.07 | -0.07 |
Normalized Diluted EPS | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 |
Average Basic Shares Outstanding | 60.04M | 60.04M | 60.04M | 60.04M | 60.04M |
Average Diluted Shares Outstanding | 63.91M | 60.04M | 60.04M | 60.04M | 60.04M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |